Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -42.40x is 64% above its 4-year average of -118.49x, near the high end of its 4-year range (-860.07x–-0.82x).
As of the fiscal period ended Thursday, December 31, 2015. 90.60% above its 12-month average of -451.23x.
Reported quarterly interest coverage; no daily interpolation. Q4 FY2015 (2015-12-31): -42.40x.
INTEREST COVERAGE RATIO
-42.40x
INTEREST COVERAGE RATIO AVG TTM
-451.23x
INTEREST COVERAGE RATIO AVG 3Y
-183.05x
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+90.60%
CURRENT VS 3Y AVG
+76.84%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.63x
median of 449 covered companies
CURRENT VS SECTOR MEDIAN
-653.02%
vs the sector median at left
Iovance Biotherapeutics, Inc.
Market Cap
$5.93B
Interest Coverage Ratio
-42.40x
TTM Avg
-451.23x
3Y Avg
-183.05x
5Y Avg
N/A
Market Cap
$5.98B
Interest Coverage Ratio
10.01x
TTM Avg
10.01x
3Y Avg
9.97x
5Y Avg
7.31x
Market Cap
$5.80B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.53B
Interest Coverage Ratio
1.30x
TTM Avg
1.31x
3Y Avg
1.26x
5Y Avg
1.25x
Market Cap
$5.56B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.40B
Interest Coverage Ratio
5.63x
TTM Avg
5.63x
3Y Avg
5.63x
5Y Avg
5.63x
Market Cap
$6.51B
Interest Coverage Ratio
15.74x
TTM Avg
19.48x
3Y Avg
15.56x
5Y Avg
15.56x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Iovance Biotherapeutics, Inc. (IOVA) | $5.93B | -42.40x | -451.23x | -183.05x | N/A |
| Ligand Pharmaceuticals Incorporated (LGND)vs › | $5.98B | 10.01x | 10.01x | 9.97x | 7.31x |
| GRAIL Inc. (GRAL)vs › | $5.98B | N/A | N/A | N/A | N/A |
| Kiniksa Pharmaceuticals International, plc (KNSA)vs › | $5.80B | N/A | N/A | N/A | N/A |
| CG Oncology Inc. (CGON)vs › | $5.77B | N/A | N/A | N/A | N/A |
| RadNet, Inc. (RDNT)vs › | $5.53B | 1.30x | 1.31x | 1.26x | 1.25x |
| MiniMed Group, Inc. Common Stock (MMED)vs › | $5.56B | N/A | N/A | N/A | N/A |
| PTC Therapeutics, Inc. (PTCT)vs › | $5.40B | 5.63x | 5.63x | 5.63x | 5.63x |
| Lantheus Holdings, Inc. (LNTH)vs › | $6.51B | 15.74x | 19.48x | 15.56x | 15.56x |
| Doximity, Inc. (DOCS)vs › | $5.36B | N/A | N/A | N/A | N/A |
Interest Coverage
-42.4x
Debt/Equity
0.06
Current Ratio
4.35
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2015-12-31 | -42.40x |
| 2014-12-31 | -860.07x |
| 2013-06-30 | -9.88x |
| 2013-03-31 | -2.06x |
| 2012-12-31 | -0.82x |
| 2012-09-30 | -12.83x |
| 2012-06-30 | -2.70x |
| 2012-03-31 | -35.45x |
| 2011-12-31 | -34.91x |
| 2011-09-30 | -183.73x |
